Skip to main content

scTCRseq and bulk TCRseq: Single-cell and bulk RNA-based TCR sequencing Analytical Validation (DFCI)

BRD ID: 3120
Tier: SOP
Source: CIMAC-CIDC Network
Document: nihms-1563655.pdf[Size: 1258.99 KB]
Number of times downloaded: 481

Description

This document describes the procedures for and the analytical validation of the RNase H-dependent PCR-enabled T Cell Receptor sequencing (rhTCRseq) assay for processing single cells and bulk RNA. It is used by the Cancer Immune Monitoring and Analysis Center (CIMAC) at the Dana-Farber Cancer Institute, which is part of the Cancer Immune Monitoring and Analysis Centers and the Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc). The final edited version of this published protocol can be found at Li S, et al. RNase H-dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis. Nature Protocols. 14, 2571-2594 (2019)(https://www.nature.com/articles/s41596-019-0195-x).